Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19

Systemic arterial hypertension (SAH) is one of the most prevalent chronic diseases worldwide and is related to serious health complications. It has been pointed out as a major risk factor for COVID-19. This study aimed to determine the impact of COVID-19 on the metabolomic profile, the correlation w...

Full description

Bibliographic Details
Main Authors:	Kamila A. Queiroz, Everton P. Vale, Manuel Martín-Pastor, Lílian G. S. Sólon, Francisco F. O. Sousa
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Pharmaceuticals
Subjects:	hypertension COVID-19 metabolomics losartan EXP3174 plasmatic level
Online Access:	https://www.mdpi.com/1424-8247/16/9/1290

Similar Items

Metabolomic Profile and Its Correlation with the Plasmatic Levels of Losartan, EXP3174 and Blood Pressure Control in Hypertensive and Chronic Kidney Disease Patients
by: Ingrid Souza Reis Santos, et al.
Published: (2023-06-01)

Influence of <i>CYP2C9</i> Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis
by: Yoon-A Park, et al.
Published: (2021-06-01)

Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
by: Jin Seong Hyeon, et al.
Published: (2020-11-01)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
by: Graham J. Moore, et al.
Published: (2021-07-01)

miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma
by: Farina Hanif, et al.
Published: (2023-05-01)

CHANGES IN BURNING WOUND IN APLLICATION OF MAGNETO-PLASMATIC THERAPY
by: M. G. Podoynitsina, et al.
Published: (2016-04-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism
by: Baiping Dong, et al.
Published: (2018-01-01)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
by: Ali Akbar Nekooeian, et al.
Published: (2021-05-01)

Effects of rearing density on rainbow trout welfare, determined by plasmatic and tissue parameters
by: Rosanna Casciano, et al.
Published: (2010-01-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
by: Noelle Castilla‐Ojo, et al.
Published: (2023-10-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
by: Gabriel Mulinari-Santos, et al.

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Changes of and genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
by: Hyeryon Lee, et al.
Published: (2019-03-01)

BarleyExpDB: an integrative gene expression database for barley
by: Tingting Li, et al.
Published: (2023-03-01)

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

Optimized and Validated RP-UPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations
by: Tadiboyina Sirisha, et al.
Published: (2015-03-01)

Effect of Losartan and Atenolol on heart rate variability in newly diagnosed essential hypertensive patient
by: Shamima Sultana, et al.
Published: (2016-08-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

Effects of losartan combined with exercise training in spontaneously hypertensive rats
by: L.F. Azevedo, et al.
Published: (2003-11-01)

Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study
by: Mariantonia Logozzi, et al.
Published: (2021-10-01)

Drug-Induced Liver Injury Due To Losartan
by: Joana Diogo, et al.
Published: (2021-11-01)

A Comparative Study of Tolerability of Losartan versus Atenolol in Essential Hypertension and Their Effect on Lipid Profile
by: Amrutha Torvi, et al.
Published: (2021-12-01)

Clinical efficacy of losartan and ramipril in male patients with hypertension depending on age, uricemia level, and hypertension type
by: V.P. Ivanov, et al.
Published: (2016-12-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Increased Plasmatic Levels of Exosomes Are Significantly Related to Relapse Rate in Patients with Oral Squamous Cell Carcinoma: A Cohort Study
by: Samuel Rodríguez-Zorrilla, et al.
Published: (2023-12-01)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
by: Ageev F.T., et al.
Published: (2016-12-01)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
by: F T Ageev, et al.
Published: (2016-12-01)

Losartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
by: EDNA GOMEZ ORTIZ, et al.
Published: (2014-01-01)

Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats
by: Shuai Dong, et al.
Published: (2023-01-01)

Does Losartan reduce the severity of COVID-19 in hypertensive patients?
by: Mohammadreza Mirjalili, et al.
Published: (2022-03-01)

Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant
by: Shahid Sarwar, et al.
Published: (2012-12-01)